ZYUS Life Sciences Corporation to Present at Sidoti Virtual Investor Conference May 8-9 May 7, 2024 06:52PM
ZYUS Announces Completion of Its Annual Filings May 7, 2024 04:00PM
ZYUS Announces Anticipated Delay in Its Annual Filings Apr 29, 2024 07:00AM
ZYUS Life Sciences Receives United States Patent No. 11,963,943 Covering Pain Management Apr 23, 2024 07:00AM
Presenting on the Emerging Growth Conference 68 Day 1 on March 6 Register Now Mar 5, 2024 07:00AM


Feb 1, 2024 07:00AM ZYUS Strengthens Expertise of Clinical Advisory Committee with the Appointment of Dr. Hance Clarke
Jan 9, 2024 07:00AM ZYUS Strengthens Leadership Team with Appointment of Vice President of Clinical Research
Jan 9, 2024 07:00AM Presenting on the Emerging Growth Conference 66 Day 1 on January 10 Register Now
Dec 5, 2023 07:00AM ZYUS Life Sciences Corporation Announces Phase 2 Clinical Trial Evaluating Trichomylin® Softgel Capsules for Advanced Cancer Pain Management
Nov 29, 2023 10:48PM ZYUS Life Sciences Corporation Reports Q3 2023 Results
Nov 21, 2023 07:45AM ZYUS Life Sciences Corporation Announces Positive Phase I Clinical Trial Results for Trichomylin® Softgels
Oct 24, 2023 07:00AM ZYUS Life Sciences Corporation Announces New Director of Investor Relations and Capital Markets
Aug 31, 2023 07:45AM ZYUS Life Sciences Corporation Obtains Health Canada Security Clearance for New Board Member Wayne Brownlee
Jun 29, 2023 07:45AM ZYUS Life Sciences Strengthens Board of Directors with the Appointment of Wayne Brownlee
Jul 7, 2015 11:32AM Biothera Pharmaceutical Inc. Announces Board of Directors